Page précédente

Service client 01 53 21 81 51

Leading Players of the Global Pharmaceutical Industry

  • The medium-term and mega trends of the industry market developments and geographical segments
  • The competitive landscape and the main corporate rankings
  • The main conclusions of our report, summarised in 10 analytical slides

Parue le 09/07/2018 -

73 pages

Réf : 8XCHE17 / GLO

1 200 € HT


2Plan de l'étude
3Liste des sociétés
PictoXerfi Global

1 Présentation de l'étude

Exclusive extracts from this 73-page-long report:

- Who are the key players?

The pharmaceutical industry remains relatively fragmented despite recent years' wave of consolidation that has seen big pharma groups focus on acquisitions to adapt to an increasingly challenging market environment. Mature-market players continue to rule the industry, with US, European and Japanese pharma groups occupying the industry's top spots. However, emerging market drug companies have gained global market share in recent years amid growing opportunities in their home markets. [...]

Groups analysed in this report include: Pfizer, Novartis, Roche, Merck & Co., Sanofi-Aventis, GlaxoSmithKline, Johnson&Johnson Pharmaceutical, AbbVie, Teva Pharmaceutical, and Bayer.

- What are the players' strategies?

Confronted with low levels of new drug approvals, the loss of patents for top-selling drugs, and a challenging market environment that is putting pressure on prices and sales, market leaders continue to focus primarily on innovation in new treatment areas as well as targeted acquisitions and partnerships to strengthen their operations. AbbVie for instance setg up an exclusive alliance with Voyager Therapeutics, a gene therapy company, to develop innovative therapies for severe neurological disorders, an area in which it sees great potential for the coming decade. Novartis also highlighted its focus on innovative gene therapy treatments by securing a US$ 9 billion buyout of US-based AveXis, while Takeda recently announced the $65bn purchase of Dublin-based Shire. […]

- What are the players' key growth and profitability drivers?

Sound revenue growth and high profitability from major players such as Bayer, AbbVie or Roche were the result of strong performances by these groups' key drug brands, newly-introduced treatments, and acquisitions. Conversely, leaders such as Novartis or Merck & Co saw sales slow or even decline as a result of increased price pressure, loss of key patents, and increased competition from generics. [...]

2 Plan de l'étude

1. Overview

1.1. The Sector

1.2. Ranking

1.3. Performance Analysis

2. Company Profiles

2.1. Pfizer

2.2. Novartis

2.3. Roche - Pharmaceuticals

2.4. Merck & Co.

2.5. Sanofi

2.6. GlaxoSmithKline

2.7. J&J Pharmaceutical

2.8. AbbVie

2.9. Teva Pharmaceutical

2.10. Bayer Pharmaceuticals

3. Sources

4. Annexes

3Liste des sociétés



Roche - Pharmaceuticals

Merck & Co.



J&J Pharmaceutical


Teva Pharmaceutical

Bayer Pharmaceuticals


PictoXerfi Global

What is the collection Xerfi Global ?

  • Reports cover market fundamentals, the market environment and prospect, corporates strategies and competition
  • Over 60 global markets and competition reports
  • Over 600 companies profiles

The reports provide :

- Decision-makers with analyses and forecasts on the major sectors of the world economy

- Alerts concerning world forecasts and major sectorial or business developments

- Key information on commodities, exchange rates and country performance

PictoDocumentation PDFPictoAjouter à ma wishlist



Cette étude a été ajoutée à votre wishlist d’études, disponible dans votre espace « Mon compte ».


Cette étude a bien été supprimée de votre wishlist d’études.


Caddie 0

L'étude a bien été ajoutée
au panier.

Voir mon panier et acheter > Je poursuis ma recherche

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des contenus adaptés à vos centres d’intérêts et nous permettre de réaliser des statistiques de visites.

En poursuivant votre navigation, vous acceptez l’utilisation de cookies.

J’accepte En savoir +